Navigation Links
Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence
Date:4/14/2009

Commercial Managed Care - Managed care plans come in many varieties and serve different purposes. This course looks at the characteristics of the different types of managed care organizations (MCOs), the different types of benefit and formulary design, the various mechanisms that plans use to manage drug utilization and costs, the impact of patent expiration and generic utilization on branded products, tactics health plans use to drive generic utilization, and potential future trends in managed care.
  • Medicare - With the launch of the Medicare Part D drug benefit, Medicare's impact on pharmaceutical and biologic product sales has dramatically increased. This course provides team members with the necessary background to understand and effectively sell to this segment of the market, including the four key components of Medicare: Parts A, B, C, & D, the characteristics of the Medicare population, the current structure and potential changes to the Part D drug benefit, and the common questions about the Medicare program.
  • Medicaid - The role and importance of Medicaid has been transformed by the Medicare Part D drug benefit. This course helps team members understand how this program has evolved and how it is managed. Topics covered in this course include, understanding the characteristics of the Medicaid population, changes to Medicaid as a result of Medicare Part D, the role of preferred drugs lists in Medicaid utilization management, and the priorities and challenges for the government in managing and paying for drugs.
  • Specialty Pharmacy - Specialty products are under increasing financial pressure in the current reimbursement environment. This course helps team members understand the management structure and economics of a physician practice that utilizes specialty products, including the day-to-day roles and responsibilities of practice managers, as well as their key challenges, the
    '/>"/>

  • SOURCE Pharmaceutical Institute
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
    2. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
    3. Process Analytical Technology (PAT): The Official Language of Pharmaceutical Outsourcing
    4. Marinus Pharmaceuticals Raises $20 Million in Series B Financing
    5. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
    6. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
    7. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
    8. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
    9. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
    10. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
    11. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... to move data would consume much less power ... as chips, transistor counts rise. , Of the ... emitters, modulators, and detectors emitters are the ... optical chips is molybdenum disulfide (MoS2), which has ... atom-thick layer. Other experimental on-chip light emitters have ...
    (Date:9/19/2014)... SAN FRANCISCO , Sept. 19, 2014 /PRNewswire/ ... announced results from preclinical studies characterizing the analgesic ... oral, peripherally-acting kappa opioid receptor agonist molecules. The ... molecule polymer medicinal chemistry platform. The ... described in the medical literature. 1,2 Kappa ...
    (Date:9/19/2014)... 2014 Cereal grain scientists, quality ... gather October 5–8, 2014, for the AACC International ... Center in Providence, Rhode Island. The comprehensive scientific ... food scientists, chemists, microbiologists, nutritionists, and those interested ... management. To date, 1,000 attendees have registered for ...
    (Date:9/18/2014)... USA (PRWEB) September 18, 2014 Bipartisan ... of a bill designed to stimulate development and commercialization ... is being praised by leaders of SPIE, the ... the Revitalizing American Manufacturing and Innovation (RAMI) Act, now ... bill’s authors have said they are optimistic that it ...
    Breaking Biology Technology:Toward optical chips 2Toward optical chips 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 3House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3
    ... ... EDMONTON, May 9 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS),a ... update on its pipeline products, HYC750 and development with,BioCyDex Inc., ... Bio. Inc. for HYC750, a technology based on hyaluronic acid that,has ...
    ... May 9 The Alexander von Humboldt,Foundation, one of ... has named Dr. Robert Knight as a winner of ... area of neurobiology.,It is the only prize that the ... Germany, the Humboldt Foundation reviews a,select group of international ...
    ... 9 ATS Medical, Inc. (Nasdaq:,ATSI), manufacturer and ... it will participate at the Rodman & Renshaw,5th ... Beach Plaza,Hotel in Monte Carlo on Tuesday, May ... Medical, will present at 9:20 a.m. local time., ...
    Cached Biology Technology:BioMS Medical Provides Update On Pipeline Products 2BioMS Medical Provides Update On Pipeline Products 3NeuroFocus Chief Science Advisor Wins Humboldt Prize 2ATS Medical to Participate at the Rodman & Renshaw 5th Annual Global Healthcare Conference 2
    (Date:9/18/2014)... ANTONIO, September 18, 2014 New research into the ... causes a severe hemorrhagic disease in humans similar to ... essential for CCHFV infection. This discovery has the potential ... the pathogen. , The research, reported in ... Pathogens and conducted by scientists at the Texas ...
    (Date:9/18/2014)... prompts millions of Americans to undertake jaunts into the countryside ... little longer within a century, according to new research. , ... of the United States as summer temperatures linger later into ... Global Ecology and Biogeography . For instance, the paper birch ... of New Hampshire could change color one to three ...
    (Date:9/18/2014)... across racial and ethnic groups describe losing eyesight ... day-to-day life, more so than other conditions including: ... of African-Americans, 49% of non-Hispanic whites, 43% of ... disease or ailment is the worst that could ... followed by AIDS/HIV. Hispanics and Asians ranked ...
    Breaking Biology News(10 mins):Research milestone in CCHF virus could help identify new treatments 2Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3
    ... has won a $1.175 million grant that will support its ... Geurts, who has spent his career looking for clues to ... contents of gold, lead and other heavy atoms, said the ... constructing and commissioning a highly complex detector system to using ...
    ... that sheds new light on the causes of Parkinson,s disease, ... energy-producing machinery, the mitochondria. A shutdown in fuel can have ... of the body,s energy despite making up only 2 percent ... the mitochondria with FDA approved drugs early on may prevent ...
    ... billion last year in health research from all public ... That amount represents only 5.6% of the $2.47 trillion ... health dollarwhich varies no more than 0.2% from 2005 ... http://www.researchamerica.org/uploads/healthdollar09.pdf . The 2009 investment grew by ...
    Cached Biology News:Grant advances quark-gluon plasma studies
 2Grant advances quark-gluon plasma studies
 3In Parkinson's disease, brain cells abandon mitochondria, researchers report 2In Parkinson's disease, brain cells abandon mitochondria, researchers report 3US invested $139 billion in health research in 2009 2
    Roll of Mesh 5m x 25cm...
    Oven mesh sheets, large, 23 x 23cm, pack of 5...
    ... (PPase-2A) is a serine/threonine phosphatase isolated from ... as the heterodimer of 60kDa (A) and ... to dephosphorylate the a-subunit of phosphorylase kinase. ... broad substrate specificity and may play a ...
    Immulon 2 HB 1x8 Strip assembled, C-bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
    Biology Products: